Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

903 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials.
Tan DJH, Tang ASP, Lim WH, Ng CH, Nah B, Fu C, Xiao J, Koh B, Tay PWL, Tan EX, Teng M, Syn N, Muthiah MD, Tamaki N, Lee SW, Kim BK, Yau T, Vogel A, Loomba R, Huang DQ. Tan DJH, et al. Among authors: loomba r. Liver Cancer. 2023 Mar 28;12(5):445-456. doi: 10.1159/000529824. eCollection 2023 Oct. Liver Cancer. 2023. PMID: 37901764 Free PMC article.
NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
Koh JH, Ng CH, Nah B, Tan DJH, Loomba R, Huang DQ; Nash HCC Transplant Collaborative. Koh JH, et al. Among authors: loomba r. Clin Gastroenterol Hepatol. 2024 Jan;22(1):197-199.e3. doi: 10.1016/j.cgh.2023.05.019. Epub 2023 May 26. Clin Gastroenterol Hepatol. 2024. PMID: 37245718 Free PMC article. No abstract available.
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Huang DQ, Ajmera V, Tomaszewski C, LaFree A, Bettencourt R, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Insel PA, Leachman S, Jung J, Collier S, Richards L, Woods K, Amangurbanova M, Bhatt A, Zhang X, Penciu OM, Zarich S, Retta T, Harkins MS, Teixeira JP, Chinnock B, Utay NS, Lake JE, Loomba R. Huang DQ, et al. Among authors: loomba r. Adv Ther. 2023 Nov;40(11):4805-4816. doi: 10.1007/s12325-023-02618-7. Epub 2023 Aug 24. Adv Ther. 2023. PMID: 37615850 Free PMC article. Clinical Trial.
Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma.
Zeng RW, Ong CEY, Ong EYH, Chung CH, Lim WH, Xiao J, Danpanichkul P, Law JH, Syn N, Chee D, Kow AWC, Lee SW, Takahashi H, Kawaguchi T, Tamaki N, Dan YY, Nakajima A, Wijarnpreecha K, Muthiah MD, Noureddin M, Loomba R, Ioannou GN, Tan DJH, Ng CH, Huang DQ. Zeng RW, et al. Among authors: loomba r. Clin Gastroenterol Hepatol. 2024 Dec;22(12):2394-2402.e15. doi: 10.1016/j.cgh.2024.06.026. Epub 2024 Jul 8. Clin Gastroenterol Hepatol. 2024. PMID: 38987014 Review.
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis.
Koh B, Xiao J, Ng CH, Law M, Gunalan SZ, Danpanichkul P, Ramadoss V, Sim BKL, Tan EY, Teo CB, Nah B, Teng M, Wijarnpreecha K, Seko Y, Lim MC, Takahashi H, Nakajima A, Noureddin M, Muthiah M, Huang DQ, Loomba R. Koh B, et al. Among authors: loomba r. Hepatology. 2024 Jul 19. doi: 10.1097/HEP.0000000000001028. Online ahead of print. Hepatology. 2024. PMID: 39028914
903 results